I am dedicated to providing the best care to patients and their families.

MEDICAL SERVICES

Departments

Programs

Languages

  • English

EDUCATION

Medical School

  • Albert Einstein College of Medicine , 1978 , Bronx , NY

Internship

  • The University Hospital , 1979 , Boston , MA

Residency

  • Longwood Area Neurological Training Program , 1982 , Boston , MA

Fellowship

  • Boston Children's Hospital , 1985 , Boston , MA

Philosophy of Care

I entered medicine to use our knowledge to advance our understanding of medical and specifically neurological problems through research, to provide the basis for improved treatments of these problems, and to use medical knowledge to take care of patients with diseases and disorders of the nervous system.

PROFESSIONAL HISTORY

Dr. Rosenberg combines research with clinical practice in sleep medicine.  His research has been devoted to understanding brain injury in premature infants, basic mechanisms of sleep, as well as neurodegenerative disorders. 

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease. Ann Neurol. 2021 May 26. View abstract
  2. Non-Cell-Autonomous Regulation of Optic Nerve Regeneration by Amacrine Cells. Front Cell Neurosci. 2021; 15:666798. View abstract
  3. Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior. Neurochem Int. 2021 03; 144:104896. View abstract
  4. The Redox Biology of Excitotoxic Processes: The NMDA Receptor, TOPA Quinone, and the Oxidative Liberation of Intracellular Zinc. Front Neurosci. 2020; 14:778. View abstract
  5. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology. 2020 08 25; 95(8):e962-e972. View abstract
  6. Cerebrovascular reactivity mapping using intermittent breath modulation. Neuroimage. 2020 07 15; 215:116787. View abstract
  7. Conditional Knockout of GLT-1 in Neurons Leads to Alterations in Aspartate Homeostasis and Synaptic Mitochondrial Metabolism in Striatum and Hippocampus. Neurochem Res. 2020 Jun; 45(6):1420-1437. View abstract
  8. Why and how to investigate the role of protein phosphorylation in ZIP and ZnT zinc transporter activity and regulation. Cell Mol Life Sci. 2020 Aug; 77(16):3085-3102. View abstract
  9. STIM1-Ca2+ signaling in coronary sinus cardiomyocytes contributes to interatrial conduction. Cell Calcium. 2020 05; 87:102163. View abstract
  10. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures. Proc Natl Acad Sci U S A. 2019 10 22; 116(43):21800-21811. View abstract
  11. Zinc homeostasis and zinc signaling in white matter development and injury. Neurosci Lett. 2019 08 10; 707:134247. View abstract
  12. Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism. Ann Neurol. 2019 06; 85(6):921-926. View abstract
  13. Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function. J Neurosci. 2019 06 19; 39(25):4847-4863. View abstract
  14. Ventral tegmental area astrocytes orchestrate avoidance and approach behavior. Nat Commun. 2019 03 29; 10(1):1455. View abstract
  15. Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1. Neurochem Int. 2019 02; 123:85-94. View abstract
  16. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl). 2018 05; 235(5):1371-1387. View abstract
  17. Chromis-1, a Ratiometric Fluorescent Probe Optimized for Two-Photon Microscopy Reveals Dynamic Changes in Labile Zn(II) in Differentiating Oligodendrocytes. ACS Sens. 2018 02 23; 3(2):458-467. View abstract
  18. Zinc chelation and Klf9 knockdown cooperatively promote axon regeneration after optic nerve injury. Exp Neurol. 2018 02; 300:22-29. View abstract
  19. Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration. Proc Natl Acad Sci U S A. 2017 01 10; 114(2):E209-E218. View abstract
  20. An Evaluation of Situation Reports and Incident Notices: The DBPR/ESRB Experience. J Public Health Manag Pract. 2016 May-Jun; 22(3):E29-38. View abstract
  21. GLT-1: The elusive presynaptic glutamate transporter. Neurochem Int. 2016 09; 98:19-28. View abstract
  22. Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations. Neurogenetics. 2016 Jan; 17(1):11-6. View abstract
  23. GLT-1 Transport Stoichiometry Is Constant at Low and High Glutamate Concentrations when Chloride Is Substituted by Gluconate. PLoS One. 2015; 10(8):e0136111. View abstract
  24. Differential Diagnosis of a Periapical Radiolucent Lesion. A Case Report and Review of the Literature. N Y State Dent J. 2015 Aug-Sep; 81(5):52-6. View abstract
  25. Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes. J Neurosci. 2015 Apr 01; 35(13):5187-201. View abstract
  26. Histological observations of pulpal replacement tissue in immature dog teeth after revascularization of infected pulps. Dent Traumatol. 2015 Jun; 31(3):243-9. View abstract
  27. Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic study. Andrology. 2015 Jan; 3(1):47-58. View abstract
  28. Treatment of a large cystlike inflammatory periapical lesion associated with mature necrotic teeth using regenerative endodontic therapy. J Endod. 2014 Dec; 40(12):2081-6. View abstract
  29. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice. Neurochem Int. 2014 Oct; 76:59-69. View abstract
  30. Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. PLoS One. 2014; 9(6):e98426. View abstract
  31. The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience. 2014 Sep 12; 276:216-38. View abstract
  32. Pathophysiology of glia in perinatal white matter injury. Glia. 2014 Nov; 62(11):1790-815. View abstract
  33. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014 Mar 26; 136(12):4551-6. View abstract
  34. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat. J Neurotrauma. 2013 Aug 15; 30(16):1434-41. View abstract
  35. Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion. J Biol Chem. 2013 Aug 09; 288(32):23128-40. View abstract
  36. Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression. Eur J Neurosci. 2013 Aug; 38(3):2477-90. View abstract
  37. Glutamate transporter expression and function in a striatal neuronal model of Huntington's disease. Neurochem Int. 2013 Jun; 62(7):973-81. View abstract
  38. Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. Am J Geriatr Psychiatry. 2013 Mar; 21(3):272-8. View abstract
  39. Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development. J Comp Neurol. 2012 Dec 01; 520(17):3912-32. View abstract
  40. Hyperbaric articaine with or without fentanyl in spinal anaesthesia: patient and observer blinded comparison. Acta Anaesthesiol Scand. 2013 Jan; 57(1):118-25. View abstract
  41. Histologic observation of a human immature permanent tooth with irreversible pulpitis after revascularization/regeneration procedure. J Endod. 2012 Sep; 38(9):1293-7. View abstract
  42. STIM1-Ca(2+) signaling is required for the hypertrophic growth of skeletal muscle in mice. Mol Cell Biol. 2012 Aug; 32(15):3009-17. View abstract
  43. Responses of immature permanent teeth with infected necrotic pulp tissue and apical periodontitis/abscess to revascularization procedures. Int Endod J. 2012 Mar; 45(3):294-305. View abstract
  44. Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts. Circ Res. 2011 Sep 16; 109(7):775-82. View abstract
  45. Reprint of "The developing oligodendrocyte: key cellular target in brain injury in the premature infant". Int J Dev Neurosci. 2011 Oct; 29(6):565-82. View abstract
  46. Repair and regeneration in endodontics. Int Endod J. 2011 Oct; 44(10):889-906. View abstract
  47. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci. 2011 Jun; 29(4):423-40. View abstract
  48. Glutamate receptors, transporters, and periventricular leukomalacia. Biology of Oligodendrocytes, Patricia Armati, editor. 2010; In Press. View abstract
  49. RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophysiol Pharmacol. 2010; 2(2):137-47. View abstract
  50. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010 Jun; 51(6):913-20. View abstract
  51. Guided tissue regeneration in periapical surgery. J Endod. 2010 Apr; 36(4):618-25. View abstract
  52. Evaluation of pathologists (histopathology) and radiologists (cone beam computed tomography) differentiating radicular cysts from granulomas. J Endod. 2010 Mar; 36(3):423-8. View abstract
  53. RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophysiol Pharmacol. 2010; 2:137-147. View abstract
  54. Neuroanatomical correlates of depression in post traumatic brain injury: preliminary results of a pilot study. J Neuropsychiatry Clin Neurosci. 2010; 22(2):231-5. View abstract
  55. Identify the endodontic treatment modalities. J Endod. 2009 Dec; 35(12):1675-94. View abstract
  56. Evidence for change in current-flux coupling of GLT1 at high glutamate concentrations in rat primary forebrain neurons and GLT1a-expressing COS-7 cells. Eur J Neurosci. 2009 Jul; 30(2):186-95. View abstract
  57. Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J Neurosci Res. 2009 Jul; 87(9):1997-2005. View abstract
  58. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res. 2009 Jul; 87(9):2078-86. View abstract
  59. Regulation of glutamate transport in developing rat oligodendrocytes. J Neurosci. 2009 Jun 17; 29(24):7898-908. View abstract
  60. Nonsurgical root canal therapy of large cyst-like inflammatory periapical lesions and inflammatory apical cysts. J Endod. 2009 May; 35(5):607-15. View abstract
  61. Pulse oximetry: review of a potential aid in endodontic diagnosis. J Endod. 2009 Mar; 35(3):329-33. View abstract
  62. Regulation of glutamate transport in developing rat oligodendrocytes. Journal of Neuroscience. 2009; 29(24):7898-7908. View abstract
  63. Evidence for change in current flux coupling of GLT1 at high glutamate concentrations in primary forebrain neurons and GLT1a expressing COS7 cells. European Journal of Science. 2009; 30(2):186-195. View abstract
  64. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci. 2008 May 14; 28(20):5321-30. View abstract
  65. Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. J Comp Neurol. 2008 May 10; 508(2):238-48. View abstract
  66. Novel lipoxygenase inhibitors as neuroprotective reagents. J Neurosci Res. 2008 Mar; 86(4):904-9. View abstract
  67. Epilepsy and dental procedures. A review. N Y State Dent J. 2008 Mar; 74(2):39-43. View abstract
  68. Hyperoxia causes maturation-dependent cell death in the developing white matter. J Neurosci. 2008 Jan 30; 28(5):1236-45. View abstract
  69. Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur J Neurosci. 2008 Jan; 27(1):66-82. View abstract
  70. One-appointment endodontic therapy: biological considerations. J Am Dent Assoc. 2007 Nov; 138(11):1456-62. View abstract
  71. Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death. Mol Med. 2007 Jul-Aug; 13(7-8):350-5. View abstract
  72. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol. 2007 Jun; 61(6):562-73. View abstract
  73. NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors. Brain Res. 2007 Jun 25; 1155:116-24. View abstract
  74. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter. J Comp Neurol. 2007 Apr 20; 501(6):879-90. View abstract
  75. Proliferation of epithelial cell rests, formation of apical cysts, and regression of apical cysts after periapical wound healing. J Endod. 2007 Aug; 33(8):908-16. View abstract
  76. Treatment planning: a new paradigm. Eur J Dent. 2007 Apr; 1(2):65. View abstract
  77. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci U S A. 2007 Feb 27; 104(9):3568-73. View abstract
  78. Comparison of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:100,000 epinephrine when used as a supplemental anesthetic. J Endod. 2007 Apr; 33(4):403-5. View abstract
  79. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter . Journal of Comparative Neurology. 2007; 501:879-890. View abstract
  80. Nitric oxide-induced adenosine inhibition of hippocampal synaptic transmission depends on adenosine kinase inhibition and is cyclic GMP independent. Eur J Neurosci. 2006 Nov; 24(9):2471-80. View abstract
  81. Nitric oxide production in the basal forebrain is required for recovery sleep. J Neurochem. 2006 Oct; 99(2):483-98. View abstract
  82. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit composition and cAMP-response element-binding protein regulate oligodendrocyte excitotoxicity. J Biol Chem. 2006 Nov 24; 281(47):36004-11. View abstract
  83. Inducible and neuronal nitric oxide synthases (NOS) have complementary roles in recovery sleep induction. Eur J Neurosci. 2006 Sep; 24(5):1443-56. View abstract
  84. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function. J Neurochem. 2006 Jul; 98(1):213-22. View abstract
  85. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res. 2006 Mar 03; 98(4):540-8. View abstract
  86. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J Biol Chem. 2006 Apr 07; 281(14):9460-70. View abstract
  87. Nitric oxide-induced adenosine inhibition of hippocampal synaptic transmission depends on adenosine kinase inhibition and is cGMP independent. European Journal of Neuorscience. 2006; 24:2471-2480. View abstract
  88. Inducible and neuronal nitric oxide have complementary roles in homeostatic sleep regulation. Eur J Neurosci. 2006; 24(5):1443-1456. View abstract
  89. AMPA receptor subunit composition and CREB regulate oligodendrocyte excitotoxicity. J Biol Chem. 2006; 281:36004-36011. View abstract
  90. Histological study of periradicular tissue responses to uninfected and infected devitalized pulps in dogs. J Endod. 2006 Jan; 32(1):34-8. View abstract
  91. Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization. J Comp Neurol. 2005 Nov 07; 492(1):78-89. View abstract
  92. Homer modulates NFAT-dependent signaling during muscle differentiation. Dev Biol. 2005 Nov 15; 287(2):213-24. View abstract
  93. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A. 2005 Jul 12; 102(28):9936-41. View abstract
  94. On the role of cholinergic neurons of the basal forebrain in regulation of recovery sleep. Abstracts of the Associated Professional Sleep Societies 17th Annual Meeting. June 18-23, 2005. Denver, Colorado, USA. 2005. View abstract
  95. Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. J Biol Chem. 2005 Jul 15; 280(28):26287-94. View abstract
  96. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem. 2005 May 20; 280(20):19587-93. View abstract
  97. The major glutamate transporter of the brain, GLT1, changes its stoichiometry. Biophysical Journal. 2005; 88(1, Part 2):25a. View abstract
  98. Do procedural errors cause endodontic treatment failure? J Am Dent Assoc. 2005 Feb; 136(2):187-93; quiz 231. View abstract
  99. GLT1 enters a high throughput mode at synaptic concentrations of glutamate. Erice Symposium on Ion Channels and Transporters, Erice, Sicily. 2005. View abstract
  100. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci. 2004 Nov 24; 24(47):10616-27. View abstract
  101. Zaprinast stimulates extracellular adenosine accumulation in rat pontine slices. Neurosci Lett. 2004 Nov 16; 371(1):12-7. View abstract
  102. Caspase-1 and poly (ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity. Eur J Neurosci. 2004 Oct; 20(7):1727-36. View abstract
  103. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci. 2004 Oct; 20(7):1713-26. View abstract
  104. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci. 2004 Oct; 20(8):2049-58. View abstract
  105. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol. 2004 Sep; 63(9):990-9. View abstract
  106. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci. 2004 Jul; 20(1):29-40. View abstract
  107. TRPC3 channels confer cellular memory of recent neuromuscular activity. Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9387-92. View abstract
  108. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A. 2004 May 18; 101(20):7751-6. View abstract
  109. Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. Oncogene. 2004 May 06; 23(21):3851-62. View abstract
  110. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004 May 05; 24(18):4412-20. View abstract
  111. Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons. Eur J Neurosci. 2004 May; 19(10):2669-81. View abstract
  112. Effect of enamel matrix proteins on the phenotype expression of periodontal ligament cells cultured on dental materials. J Biomed Mater Res A. 2004 Apr 01; 69(1):172-9. View abstract
  113. Effect of enamel matrix proteins on the periodontal connective tissue-material interface after wound healing. J Biomed Mater Res A. 2004 Apr 01; 69(1):180-7. View abstract
  114. Identification of gammadeltaT lymphocytes in human periapical lesions. Oral Microbiol Immunol. 2004 Apr; 19(2):106-10. View abstract
  115. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci. 2004 Feb 18; 24(7):1531-40. View abstract
  116. GLT1 is the major electrogenic glutamate transporter in cultured rat neurons. Biophysical Journal. 2004; v. 86 (1, Part 2):613a. View abstract
  117. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci. 2004 Feb 04; 24(5):1136-48. View abstract
  118. Modulation of expression of the glutamate transporter GLT1/EAAT2 may be involved in the pathogenesis of PVL . Program No. 503.20. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2004; Online. View abstract
  119. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. Journal of Neuroscience. 2004; 24:1531-1540. View abstract
  120. Interaction of the glutamate transporter GLT1b with the PDZ protein PICK1 and GLT1a. Program No. 503.16. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2004; Online. View abstract
  121. The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. Journal of Neuroscience. 2004; 24:1136-1148. View abstract
  122. Peroxynitrite induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. Journal of Neuroscience. 2004; 24:10616-10627. View abstract
  123. Novel role of MGluRs in oligodendrocyte excitotoxicity and oxidative stress. Proceedings of the National Academy of Science USA. 2004; 101:7751-7756. View abstract
  124. Zinc release and 12-lipoxygenase activation are required for peroxynitrite-induced toxicity to mature oligodendrocytes . Program No. 806.19. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2004; Online. View abstract
  125. Caspase-1 and poly (ADP-ribose) polymerase inhibitors protect against peroxynitrite-induced neurotoxicity by a direct scavenging effect. European Journal of Neuroscience. 2004; 20:1727-1736. View abstract
  126. Oligodendrocyte excitotoxicity determined by glutamate diffusion and Glur2-free AMPA receptors . Program No. 919.14. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2004; Online. View abstract
  127. Glutamate receptor mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. Journal of Neuroscience. 2004; 24:4412-4420. View abstract
  128. Nitric oxide induces cell death through mitochondrial dysfunction and Apoptosis-Inducing Factor translocation in developing oligodendrocytes. European Journal of Neuroscience. 2004; 20:1713-1726. View abstract
  129. Elevation of intracellular cyclic AMP evokes activity dependent release of adenosine in cultured rat forebrain neurons. European Journal of Neuroscience. 2004; 19:2669-2681. View abstract
  130. Developmental upregulation of MnSOD in rat oligodendrocytes confers protection against oxidative toxicity. European Journal of Neuroscience. 2004; 20:29-40. View abstract
  131. On the role of neuronal and inducible nitric oxide synthases in regulation of sleep need . Program No. 78.5. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2004; Online. View abstract
  132. Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci. 2003 Jul 02; 23(13):5816-26. View abstract
  133. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003 Jul 08; 100(14):8514-9. View abstract
  134. The role of nitric oxide in regulation of sleep need. Abstracts of the Associated Professional Sleep Societies 17th Annual Meeting. June 3-8, 2003. Chicago, Illinois, USA. 2003. View abstract
  135. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci U S A. 2003 May 27; 100(11):6801-6. View abstract
  136. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003 May; 62(5):441-50. View abstract
  137. NMDA receptor-mediated extracellular adenosine accumulation in rat forebrain neurons in culture is associated with inhibition of adenosine kinase. Eur J Neurosci. 2003 Mar; 17(6):1213-22. View abstract
  138. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res. 2003 Jan 15; 71(2):237-45. View abstract
  139. Transient expression of the glutamate transporter GLT1a in cerebral white matter of the developing rat brain . Program No. 372.9. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2003; Online. View abstract
  140. AMPA/KA receptor mediated excitotoxicity induced by oxygen-glucose deprivation in cultured oligodendrocyte lineage cells. Proceedings of the National Academy of Science USA. 2003; 100:6801-6806. View abstract
  141. Interaction of GLT1b with the synaptic protein PICK1. Gordon Conference: Excitatory Amino Acids and Brain Function, Mt. Holyoke, MA. 2003. View abstract
  142. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. Journal of Neuroscience. 2003; 23:5816-5826. View abstract
  143. Nitric oxide: does it mediate effects of prolonged wakefulness? . Program No. 616.14. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2003; Online. View abstract
  144. Expression of inducible nitric oxide synthase and endothelial nitric oxide synthase in reactive astrocytes in human periventricular leukomalacia. Program No. 352.17. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2003; Online. View abstract
  145. Functional interaction of GLT1b, a variant form of the glutamate transporter GLT1, with PICK1 . Program No. 372.8. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2003; Online. View abstract
  146. Call-tracking data and the public health response to bioterrorism-related anthrax. Emerg Infect Dis. 2002 Oct; 8(10):1088-92. View abstract
  147. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci. 2002 Sep; 16(6):1015-24. View abstract
  148. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 2002 Apr 01; 22(7):2478-86. View abstract
  149. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J Neurosci. 2002 Mar 15; 22(6):2142-52. View abstract
  150. The glutamate transporter GLT1b & PICK1 both localize to pre- and post-synaptic processes of pyramidal neurons as well as astrocytes of intact adult rat. Program No. 44.7. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2002; Online. View abstract
  151. The toll-like receptor TL4 is necessary for lipopolysaccharide-induced oligodendrocytre injury in the CNS. Journal of Neuroscience. 2002; 22:2478-2486. View abstract
  152. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. Journal of Neuroscience. 2002; 22:2142-2152. View abstract
  153. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci. 2001 Nov 15; 21(22):9068-76. View abstract
  154. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J. 2001 Nov 15; 20(22):6414-23. View abstract
  155. Quantitation of catecholamines in inflamed human dental pulp by high-performance liquid chromatography. J Endod. 2001 Feb; 27(2):73-5. View abstract
  156. A variant form of the glutamate transporter GLT1 interacts with the PDZ protein PICK1 in rat forebrain. Program No. 607.4. 2001 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. 2001; Online. View abstract
  157. Expression of cGMP specific phosphodiesterase 9a mRNA in the rat brain. Journal of Neuroscience. 2001; 21:9068-9076. View abstract
  158. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000 Dec 15; 20(24):9235-41. View abstract
  159. NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro. J Neurosci. 2000 Dec 01; 20(23):8831-7. View abstract
  160. Differential expression of glutamate receptor subtypes in human brainstem sites involved in perinatal hypoxia-ischemia. J Comp Neurol. 2000 Nov 13; 427(2):196-208. View abstract
  161. Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity. J Neurosci. 2000 Aug 15; 20(16):6294-301. View abstract
  162. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci. 2000 Mar 15; 20(6):2409-17. View abstract
  163. Nitric oxide stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity. Journal of Neuroscience. 2000; 20:6294-6301. View abstract
  164. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. Journal of Neuroscience. 2000; 20:2409-2417. View abstract
  165. NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro. Journal of Neuroscience. 2000; 20:8831-8837. View abstract
  166. NBQX attenuates excitotoxicity in developing oligodendrocytes in vivo. Journal of Neuroscience. 2000; 20:9235-9241. View abstract
  167. An evaluation of resin-ionomers to prevent coronal microleakage in endodontically treated teeth. J Clin Dent. 2000; 11(1):16-9. View abstract
  168. A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death. J Neurosci Methods. 1999 Sep 15; 91(1-2):47-54. View abstract
  169. Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J Neurochem. 1999 Aug; 73(2):476-84. View abstract
  170. Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J Biol Chem. 1998 Nov 06; 273(45):29626-34. View abstract
  171. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci. 1998 Aug 15; 18(16):6241-53. View abstract
  172. Dihydrokainate-sensitive neuronal glutamate transport is required for protection of rat cortical neurons in culture against synaptically released glutamate. Eur J Neurosci. 1998 Aug; 10(8):2523-31. View abstract
  173. The effect of occlusal reduction on pain after endodontic instrumentation. J Endod. 1998 Jul; 24(7):492-6. View abstract
  174. Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial? Prog Brain Res. 1998; 118:53-71. View abstract
  175. High affinity glutamate transport in rat cortical neurons in culture. Mol Pharmacol. 1998 Jan; 53(1):88-96. View abstract
  176. Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial?. Progress in Neurobiology. 1998; 18:53-71. View abstract
  177. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. Journal of Neuroscience. 1998; 18:6241-6253. View abstract
  178. The effect of endodontic materials on periodontal ligament cell proliferation, alkaline phosphatase activity, and extracellular matrix protein synthesis in vitro. J Endod. 1997 Aug; 23(8):494-8. View abstract
  179. Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase (CD39) gene. Brain Res Mol Brain Res. 1997 Jul; 47(1-2):295-302. View abstract
  180. NMDA receptor-mediated neurotoxicity: a paradoxical requirement for extracellular Mg2+ in Na+/Ca2+-free solutions in rat cortical neurons in vitro. J Neurochem. 1997 May; 68(5):1836-45. View abstract
  181. An in-vitro evaluation of sealer placement methods. Int Endod J. 1997 May; 30(3):181-6. View abstract
  182. Potential therapeutic intervention following hypoxic/ischemic insult. Mental Retardation and Developmental Disabilities Reviews. 1997; 3:76-84. View abstract
  183. NMDA receptor activation inhibits neuronal volume regulation after swelling induced by veratridine-stimulated Na+ influx in rat cortical cultures. J Neurosci. 1996 Dec 01; 16(23):7447-57. View abstract
  184. The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur J Neurosci. 1996 Sep; 8(9):1840-52. View abstract
  185. Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture. J Neurosci. 1996 Sep 01; 16(17):5372-81. View abstract
  186. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem. 1996 Aug; 67(2):566-73. View abstract
  187. Forskolin evokes extracellular adenosine accumulation in rat cortical cultures. Neurosci Lett. 1996 Jun 14; 211(1):49-52. View abstract
  188. Comparison of fatigue for three prefabricated threaded post systems. J Prosthet Dent. 1996 Feb; 75(2):148-53. View abstract
  189. Extracellular synthesis of cyclic adenosine diphospho-ribose from NAD by rat cortical astrocytes in culture. Journal of Neuroscience. 1996; 16:5372-5381. View abstract
  190. NMDA receptor activation inhibits neuronal volume regulation following swelling induced by veratridine-stimulated sodium influx in rat cortical cultures. Journal of Neuroscience. 1996; 16:7447-7457. View abstract
  191. The glutamate transport inhibitor l-trans-pyrrolidine-2,4-dicarboxylate evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. European Journal of Neuroscience. 1996; 8:1840-1852. View abstract
  192. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res. 1995 Dec; 12(12):1997-2002. View abstract
  193. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci Lett. 1995 Nov 17; 200(2):93-6. View abstract
  194. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res. 1995 Sep 18; 692(1-2):227-32. View abstract
  195. Quantitation of catecholamines in uninflamed human dental pulp tissues by high-performance liquid chromatography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jul; 80(1):83-6. View abstract
  196. beta-Bungarotoxin blocks phorbol ester-stimulated phosphorylation of MARCKS, GAP-43 and synapsin I in rat brain synaptosomes. Toxicon. 1995 Jun; 33(6):747-62. View abstract
  197. An in vitro evaluation of the irrigating characteristics of ultrasonic and subsonic handpieces and irrigating needles and probes. J Endod. 1995 May; 21(5):277-80. View abstract
  198. Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin. J Neurochem. 1995 Apr; 64(4):1742-8. View abstract
  199. TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line. J Neurosci. 1995 Apr; 15(4):3172-7. View abstract
  200. Topa quinone, a kainate-like agonist and excitotoxin, is generated by a catecholaminergic cell line. Journal of Neuroscience. 1995; 15:3172-3177. View abstract
  201. A comparison of the apical seals achieved using retrograde amalgam fillings and the Nd:YAG laser. J Endod. 1994 Dec; 20(12):595-7. View abstract
  202. Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA. J Neurochem. 1994 Sep; 63(3):879-85. View abstract
  203. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience. 1994 Sep; 62(2):399-406. View abstract
  204. Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J Neurosci. 1994 May; 14(5 Pt 2):2953-65. View abstract
  205. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994 Mar 03; 330(9):613-22. View abstract
  206. Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett. 1994 Feb 28; 168(1-2):189-92. View abstract
  207. Box I and II motif from myelin basic protein gene promoter binds to nuclear proteins from rodent brain. J Mol Neurosci. 1994; 5(1):27-37. View abstract
  208. Further evidence that pyrroloquinoline quinone interacts with the NMDA receptor redox modulatory site. Neuroscience Letters. 1994; 168:189-192. View abstract
  209. Beta-adrenergic receptor mediated regulation of extracellular adenosine in cerebral cortex in culture. Journal of Neuroscience. 1994; 14:2953-2965. View abstract
  210. Box I and II motif from myelin basic protein gene promoter binds specifically to nuclear proteins from rodent brain. Journal of Molecular Neuroscience. 1994; 5:27-37. View abstract
  211. The putative essential nutrient pyrroloquinoline quinone is a neuroprotectant in a rodent stroke model. Neuroscience. 1994; 62:339-406. View abstract
  212. Multifactor behavioral treatment of chronic sleep-onset insomnia using stimulus control and the relaxation response. A preliminary study. Behav Modif. 1993 Oct; 17(4):498-509. View abstract
  213. Nonenzymatic conversion of 3,4-dihydroxyphenylalanine to 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylalanine quinone in physiological solutions. J Neurochem. 1993 Sep; 61(3):911-20. View abstract
  214. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci. 1993 Apr; 13(4):1441-53. View abstract
  215. Localization of synapses in rat cortical cultures. Neuroscience. 1993 Mar; 53(2):495-508. View abstract
  216. The asymmetric distribution of phosphatidylcholine in rat brain synaptic plasma membranes. Neurochem Int. 1993 Feb; 22(2):189-95. View abstract
  217. Localization of synapses in rat cerebral cortex in dissociated cell culture. Neuroscience. 1993; 53:495-508. View abstract
  218. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. Journal of Neuroscience. 1993; 13:1441-1453. View abstract
  219. Non-enzymatic conversion of 3,4-dihydroxyphenylalanine (DOPA) to 2,4,5-trihydroxyphenylalanine (TOPA) and TOPA quinone in physiological solutions. Journal of Neurochemistry. 1993; 61:911-920. View abstract
  220. Neuronal injury evoked by depolarizing agents in rat cortical cultures. Neuroscience. 1992 Dec; 51(4):931-9. View abstract
  221. Inhibition of phosphorylation of synapsin I and other synaptosomal proteins by beta-bungarotoxin, a phospholipase A2 neurotoxin. J Neurochem. 1992 Dec; 59(6):2030-9. View abstract
  222. Controlling glutamine/glutamate related neuronal injury. 1992. View abstract
  223. Effects of snake venom phospholipase A2 toxins (beta-bungarotoxin, notexin) and enzymes (Naja naja atra, Naja nigricollis) on aminophospholipid asymmetry in rat cerebrocortical synaptosomes. Biochem Pharmacol. 1992 Sep 25; 44(6):1073-83. View abstract
  224. Glutathione prevents 2,4,5-trihydroxyphenylalanine excitotoxicity by maintaining it in a reduced, non-active form. Neurosci Lett. 1992 Sep 14; 144(1-2):233-6. View abstract
  225. Method of resisting neurodegenerative disorders. 1992. View abstract
  226. Method of resisting neurodegenerative disorders. 1992. View abstract
  227. Functional significance of cyclic AMP secretion in cerebral cortex. Brain Res Bull. 1992 Sep-Oct; 29(3-4):315-8. View abstract
  228. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci. 1992 Jun; 12(6):2362-9. View abstract
  229. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci. 1992 Jan; 12(1):56-61. View abstract
  230. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. Journal of Neuroscience. 1992; 12:56-61. View abstract
  231. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. Journal of Neuroscience. 1992; 12:2362-2369. View abstract
  232. 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin. Proc Natl Acad Sci U S A. 1991 Jun 01; 88(11):4865-9. View abstract
  233. Accumulation of extracellular glutamate and neuronal death in astrocyte-poor cortical cultures exposed to glutamine. Glia. 1991; 4(1):91-100. View abstract
  234. 2,4,5-Trihydroxyphenylalanine in solution forms a non-NMDA glutamatergic agonist and neurotoxin. Proceedings of the National Academy of Science U.S.A. 1991; 88:4865-4869. View abstract
  235. Inhibitory effect of EDTA.Ca2+ on the hydrolysis of synaptosomal phospholipids by phospholipase A2 toxins and enzymes. Biochem Pharmacol. 1990 Nov 15; 40(10):2233-9. View abstract
  236. A 3,4-dihydroxyphenylalanine oxidation product is a non-N-methyl-D-aspartate glutamatergic agonist in rat cortical neurons. Neurosci Lett. 1990 Aug 14; 116(1-2):168-71. View abstract
  237. A dopa oxidation product is a non-NMDA glutamatergic agonist. Neuroscience Letters. 1990; 116:168-171. View abstract
  238. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett. 1989 Aug 28; 103(2):162-8. View abstract
  239. Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J Neurosci. 1989 Aug; 9(8):2654-63. View abstract
  240. Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. Journal of Neuroscience. 1989; 9:2654-2663. View abstract
  241. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci. 1988 Aug; 8(8):2887-94. View abstract
  242. Cell and fiber-type distribution of dystrophin. Neuron. 1988 Jul; 1(5):411-20. View abstract
  243. Catecholamine toxicity in cerebral cortex. Journal of Neuroscience. 1988; 8:2887-2894. View abstract
  244. A small subset of cortical astrocytes in culture accumulates glycogen. Int J Dev Neurosci. 1987; 5(3):227-35. View abstract
  245. A small subset of cortical astrocytes in culture accumulates glycogen. International Journal of Developmental Neuroscience. 1987; 5:227-235. View abstract
  246. Effects of norepinephrine on rat neocortical neurons in dissociated cell culture. Brain Res. 1985 Oct 07; 344(2):369-72. View abstract
  247. Glycogen accumulation in rat cerebral cortex in dissociated cell culture. J Neurosci Methods. 1985 Oct-Nov; 15(2):101-12. View abstract
  248. Local anesthetic complications: a review and case report. N Y J Dent. 1985 Feb; 55(2):55-8. View abstract
  249. Glycogen cytochemistry in cerebral cortex in dissociated cell culture. Journal of Neuroscience Methods. 1985; 15:101-112. View abstract
  250. Afferent connections of the perirhinal cortex in the rat. J Comp Neurol. 1983 Oct 20; 220(2):168-90. View abstract
  251. Phospholipid distribution and stimulation of methylation during denervation and reinnervation in skeletal muscle. Neurochem Int. 1983; 5(6):763-71. View abstract
  252. Occlusion, the dental pulp, and endodontic treatment. Dent Clin North Am. 1981 Jul; 25(3):423-37. View abstract
  253. Comparison of endodontic measurement controls using a paralleling technique with a grid and a conventional measurement. Oral Surg Oral Med Oral Pathol. 1980 Feb; 49(2):157-61. View abstract
  254. Differential phospholipid hydrolysis by phospholipase C in sarcolemma of muscles with calcium or sodium generated action potentials. Toxicon. 1980; 18(1):71-86. View abstract
  255. A quantitative examination of immunoglobulins in bovine gingiva and dental pulp. J Endod. 1979 Jun; 5(6):176-80. View abstract
  256. The effects of etching enamel with acid on human dental pulp. A preliminary study. Oral Surg Oral Med Oral Pathol. 1979 Apr; 47(4):359-63. View abstract
  257. Single file transport: Implications for ion and water movement through gramicidin A channels. Membrane Transport Processes. C.F. Stevens and R.W. Tsien, editors. 1979; 3:73-88. View abstract
  258. The gramicidin channel: water permeability and ion-water coupling. 1979. View abstract
  259. Histologic identification of mast cells in human dental pulp. Oral Surg Oral Med Oral Pathol. 1978 Oct; 46(4):559-66. View abstract
  260. Water permeability of gramicidin A-treated lipid bilayer membranes. J Gen Physiol. 1978 Sep; 72(3):341-50. View abstract
  261. Interaction of ions and water in gramicidin A channels: streaming potentials across lipid bilayer membranes. J Gen Physiol. 1978 Sep; 72(3):327-40. View abstract
  262. Interaction of ions and water in gramicidin A channels. Streaming potentials across lipid bilayer membranes. Journal of General Physiology. 1978; 72:327-340. View abstract
  263. Determination of the accuracy of the Sono-Explorer for establishing endodontic measurement control. J Endod. 1976 Oct; 2(10):295-7. View abstract
  264. The effect of phospholipases and proteases on the binding of gamma-aminobutyric acid to junctional complexes of rat cerebellum. Biochim Biophys Acta. 1976 Jul 15; 436(4):741-56. View abstract
  265. Role of the anesthetic solution in intrapulpal anesthesia. J Endod. 1975 Jan; 1(1):26-7. View abstract
  266. Periapical repair: apparent or real? N Y State Dent J. 1974 May; 40(5):283-5. View abstract
  267. The endodontic aspect of complete root amputation. N Y State Dent J. 1973 Nov; 39(9):537-9. View abstract
  268. Periapical surgery on a two-rooted maxillary central incisor. N Y State Dent J. 1973 Apr; 39(4):218-9. View abstract
  269. Exteroceptive stimulation of maternal behavior in the naive rat. Physiol Behav. 1972 Apr; 8(4):595-8. View abstract
  270. Gold posts. Common problems in preparation and technique for fabrication. N Y State Dent J. 1971 Dec; 37(10):601-6. View abstract
  271. Lipid changes in tri-o-cresylphosphate-induced neuropathy. Toxicol Appl Pharmacol. 1970 Mar; 16(2):461-74. View abstract